Comparing surgical and conservative treatment of keratinizing squamous metaplasia (leukoplakia) of the bladder: a systematic review

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

BACKGROUND: Leukoplakia is a condition requiring histological confirmation and is associated with persistent symptoms of recurrent cystitis. No universal treatment standards are currently available.

AIM: This study aimed to compare surgical and conservative treatment approaches for keratinizing squamous metaplasia (leukoplakia) of the bladder in adults.

METHODS: A scientific data search was conducted in MEDLINE/PubMed, Scopus, Web of Science, the Russian Science Citation Index, and other databases (last search: September 2025). Comparative studies and surgical case series following drug therapy failure were included; single case reports, pediatric cases, and schistosomiasis-associated cases were excluded. The primary outcome was clinical and endoscopic resolution, i.e. symptom disappearance and complete epithelialization on follow-up cystoscopy. Secondary outcomes included recurrence, adverse events, cancer occurrence, and quality-of-life measures. Risk of bias was assessed using ROBINS-I and RoB 2.0 tools (ROBINS-I prioritized), and overall certainty of evidence was evaluated using the GRADE approach. A random-effects meta-analysis (DerSimonian–Laird method with Hartung–Knapp adjustment) with heterogeneity assessment (I2, Cochran χ2) was pre-specified but was limited by small sample sizes and substantial heterogeneity.

RESULTS: Seven studies were included (0 randomized controlled trials), comprising a total of 826 patients. Conservative strategies (antibacterial and anti-inflammatory therapy, intravesical instillations) rarely resulted in lesion regression and provided mainly short-term symptom relief. Endoscopic removal or ablation of lesions (laser ablation, argon plasma coagulation, mono- or bipolar transurethral resection) demonstrated high rates of clinical and morphological resolution (80%–97%) and meaningful improvements in quality of life. In the largest series, the 5-year recurrence risk after complete endoscopic removal was 13.9%, with no cases of cancer reported over a median follow-up of 49 months. Laser ablation was associated with fewer coarse scars in the surgical treatment area and greater reduction in pain symptoms compared with transurethral resection; serious complications were rare. Overall certainty of evidence was low to very low (due to retrospective study designs, confounding, and selective reporting), although effect directions were consistent.

CONCLUSION: In symptomatic keratinizing squamous metaplasia of the urothelium, an active management approach is justified, comprising biopsy-based diagnosis verification, elimination of inflammatory triggers, and organ-sparing endoscopic removal of lesions (preferably using laser techniques), followed by scheduled follow-up cystoscopy. Conservative therapy plays an adjunctive role and rarely provides durable resolution. The quality of available evidence remains low to very low, underscoring the need for prospective comparative studies.

作者简介

Vladimir Vorobev

Irkutsk State Medical University; Bashkir State Medical University

编辑信件的主要联系方式.
Email: denecer@yandex.ru
ORCID iD: 0000-0003-3285-5559
SPIN 代码: 9896-6243

MD, Dr. Sci. (Medicine)

俄罗斯联邦, Irkutsk; Ufa

Inga Kosova

Russian Medical Academy of Continuous Professional Education; City Clinical Hospital V.P. Demikhov

Email: kosovainga@mail.ru
ORCID iD: 0000-0002-0051-0583

MD, Dr. Sci. (Medicine)

俄罗斯联邦, Moscow; Moscow

Khalid Ibishev

Rostov State Medical University

Email: ibishev22@mail.ru
ORCID iD: 0000-0002-2954-842X
SPIN 代码: 9614-0335

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, Rostov-on-Don

参考

  1. Pandey T, Pandey S, Goel A, et al. Leukoplakia of the urinary bladder: keratinising squamous metaplasia. BMJ Case Rep. 2018;2018:bcr2018227019. doi: 10.1136/bcr-2018-227019
  2. Goncharov ID, Ibishev KHS, Alkhshash AMS, et al. Leukoplakia of the bladder: review of publications from 2018 to 2023. Urologiia. 2024;(2):88–91. doi: 10.18565/urology.2024.2.88-91 EDN: NQPGIE
  3. Ibishev KHS, Lapteva TO, Todorov SS, et al. Pathomorphological criteria for the differential diagnosis of leukoplakia and chronic recurrent papillomavirus cystitis. Urologiia. 2024;(3):28–32. doi: 10.18565/urology.2024.3.28-32 EDN: AIIFBM
  4. Khan MS, Thornhill JA, Gaffney E, et al. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. Eur Urol. 2002;42(5):469–474. doi: 10.1016/s0302-2838(02)00358-5
  5. Batura D, Mitsopoulos G. Keratinising cystitis with intestinal metaplasia following a Crohn’s vesico-intestinal fistula. Int Urol Nephrol. 2015;47(5): 803–804. doi: 10.1007/s11255-015-0966-4
  6. Amin MB, McKenney JK, Paner GP, et al. Icud-eau international consultation on bladder cancer 2012: Pathology. European Urology. 2013;63(1):16–35. doi: 10.1016/j.eururo.2012.09.063
  7. Yi Z, Ou Z, Guo X, et al. Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study. Transl Androl Urol. 2021;10(2):734–740. doi: 10.21037/tau-20-948 EDN: GWNSRP
  8. Kulchavenya EV, Brizhatyuk EV. Bladder leukoplakia—is the surgical aggression justified? Urologiia. 2014;(4):21–24. EDN: SVNUDT
  9. Neimark AI, Ilyinskaya EV, Lebedeva RN, Taranina TS. Diagnosis and treatment of bladder leukoplakia in women. Urologiia. 2009;(2):18–22. EDN: KVQKLL
  10. Al-Shukri SK, Kuzmin IV, Slesarevskaya MN, Sokolov AV. Choice of treatment tactics for leukoplakia of the bladder in women with chronic cystitis. Urology Reports (St. Petersburg). 2015;5(1):90–91. doi: 10.17816/uroved5190-91 EDN: TRSGXV
  11. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi: 10.1186/s13643-021-01626-4 EDN: LZOATG
  12. Wang H, Chong T, Tang XY, et al. Transurethral resection in women with symptomatic keratinizing squamous metaplasia of urinary bladder: a retrospective study of 92 cases. Low Urin Tract Symptoms. 2020;12(2):137–142. doi: 10.1111/luts.12294
  13. Ozbey I, Aksoy Y, Polat O, et al. Squamous metaplasia of the bladder: findings in 14 patients and review of the literature. Int Urol Nephrol. 1999;31(4):457–461. doi: 10.1023/A:1007107110222 EDN: AGHREF
  14. Slesarevskaya MN, Sokolov AV, Zharkikh AV. Advantages of laser coagulation for bladder leukoplakia. Urology Reports (St. Petersburg). 2012;2(1):16–22. doi: 10.17816/uroved2116-22 EDN: PZTIWF
  15. Staack A, Schlechte H, Sachs M, et al. Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53. Int J Urol. 2006;13(8):1092–1097. doi: 10.1111/j.1442-2042.2006.01503.x
  16. McKenney JK. Precursor lesions of the urinary bladder. Histopathology. 2019;74(1):68–76. doi: 10.1111/his.13762
  17. Yakovets EA, Chudnovets IY, Trutnev VP, Yunusov IR. Determination of treatment tactics in patients with chronic cystitis complicated by bladder leukoplakia. Pharmacology & Pharmacotherapy. 2022;(4):34–38. doi: 10.46393/27132129_2022_4_34 EDN: QBRSVU

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2025

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).